Global Pharmaceutical Excipients Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Excipient Type (Polymers, Alcohols, Sugars, Minerals, Others), By Formulation Type (Oral, Topical, Parenteral, Others), By Functionality (Coating Agents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Colorants, Emulsifying Agents, Buffering Agents, Others), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2022 To 2027

Published:  Mar 2022 Report Code: KSI061611832 Pages: 126

The Global Pharmaceutical Excipients Market is projected to witness a CAGR of 9.17% during the forecast period to reach a total market size of US$10.711 billion by 2027, increasing from US$5.795 billion in 2020.

Introduction

Excipients are the pharmacologically inactive substances added along with the active drug substance to streamline the manufacture of the drug product and aid in lubricity, flowability, disintegration, taste, and may confer some form of antimicrobial function also facilitating physiological absorption of the drug. Some of the excipients used in pharmaceutical industries include fillers, binders, lubricants, flavoring agents, sweeteners, chelating agents, solvents, co-solvents, etc. To provide the bulk finished dosage formulations consistent in physical and chemical, the formulator is highly dependent on the pharmaceutical excipients. 

Market Drivers

Tablets, capsules, oral liquids, topical creams and gels, implants, eye products, injectable products,  inhalers, transdermal patches, and suppositories are some of the dose forms available. Pharmaceutical excipients are used in pharmaceutical dosage forms to help the production process, protect, support, or increase stability.

Cancer, chronic lung disease, stroke, diabetes, and other chronic illnesses are today's leading causes of mortality and disability. In the United States alone, six out of ten individuals suffer from a chronic illness, needing frequent medication. According to International Diabetes Federation (IDF), Approximately 463 million adults (20-79 years) were living with diabetes in 2019; by 2045, this will rise to 700 million, indicating a high demand for medication and thus Pharmaceutical Excipients.

Growth Factors

Increasing  in research and development (R&D)

Increased research and development in pharmaceutical formulations employ multi-functional excipients to improve the manufacturing process and product quality. Excipients play a crucial role in assisting pharmaceutical makers in providing improved patient support by enhancing compliance and treatment efficacy.

Increasing diseases

With increasing chronic diseases, the growing generics market leads to an increase in the development of excipients is the major factor driving the market growth. With the advancement of drug development, there is an increase in pharmaceutical excipients.

Restrains

Pharmaceutical Excipients require mandatory inspections by the regulatory authorities of the manufacturing site. The industry lacks separate guidelines for approval and manufacturing of excipients is impending R&D initiatives related to excipients. If a new drug approval fails, the excipient also fails, even if it is not related to the excipient. Moreover, a considerable amount of time and cost goes into creating an excipient.

Impact of COVID–19 on the Pharmaceutical Excipients Market:

Pharmaceutical Excipients have seen growth during the pandemic not just to treat COVID-19 patients worldwide but also to make vaccines for COVID-19. Drugs like hydroxychloroquine and Remdesivir showed positive results against the virus. They were high in demand during the COVID-19 peaks.  With the approval of various WTO vaccines, production has increased to the fullest capacity, causing an increase in the demand for  Pharmaceutical Excipients.

Competitive Insights

To name a few market players for the Global Pharmaceutical Excipients Market are Ashland Global Holdings, DuPont, BASF SE, Roquette Feres, Evonik Industries AG, and Croda International, amongst others. The players in the market implement growth strategies such as product launches, mergers, acquisitions, etc., to gain a competitive advantage over their competitors. For instance,

  • In August 2021, Croda expanded its High Purity Pharmaceutical Excipients Manufacturing Capability by opening a facility in  Mill Hall.
  • In January 2021 – Croda International Plc entered into a global sales and marketing agreement with Genesis Biosciences. This new partnership further expands Croda’s existing portfolio of safe and sustainable cleaning raw materials.
  • In June 2021, Croda International Plc completed the acquisition of Parfex S.A. ('Parfex'), a fine fragrance business located in Grasse, France, for a total enterprise value of €45 million in June 2021 through its wholly-owned subsidiary Iberchem.
  • In May 2021, Aceto expanded excipient manufacturing with the Finar acquisition. Finar, a manufacturer, supplier, and distributor of pharmaceutical excipients, lab chemicals, aquaculture inputs, and food-grade additives, has announced that Aceto has acquired a majority share in the company. Aceto's production base, R&D skills, and quality expertise will benefit from the purchase.
  • In 2021, Evonik announced the opening of a new biomaterials plant in Birmingham, Alabama. It is a multi-functional facility with over 2,800 square meters of structure. The facility has been successfully inspected by the US and EU health authorities.
  • Roquette opened its online pharma marketplace, which is powered by Knowde. The e-commerce platform will provide users with access to Roquette’s products in smaller quantities for the first time.

Global Pharmaceutical Excipients Market Scope:

Report Metric Details
 Market size value in 2020  US$5.795 billion
 Market size value in 2027  US$10.711 billion
 Growth Rate  CAGR of 9.17% from 2020 to 2027
 Base year  2020
 Forecast period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments covered  Excipient Type, Formulation Type, Functionality, Distribution Channel, And   Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Ashland Global Holdings, DuPont, BASF SE, Roquette Feres, Evonik Industries AG, Croda International, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation
 Customization scope  Free report customization with purchase

 

Key Segmentation:

  • By excipient type
    • Polymers
    • Alcohols
    • Sugars
    • Minerals
    • Others
  • By formulation type
    • Oral
    • Topical
    • Parenteral
    • Others
  • By functionality
    • Coating Agents
    • Flavoring Agents & Sweeteners
    • Lubricants & Glidants
    • Colorants
    • Emulsifying Agents
    • Buffering Agents
    • Others
  • By Distribution Channel
    • Online
    • Offline
  •  By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • China
      • Australia
      • Japan
      • South Korea
      • India
      • Thailand
      • Taiwan
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the pharmaceutical excipients market size by 2027?
A1. The global pharmaceutical excipients market is projected to reach a market size of US$10.711 billion by 2027.


Q2. What is the size of the global pharmaceutical excipients market?
A2. Pharmaceutical Excipients Market was valued at US$5.795 billion in 2020.


Q3. What are the growth prospects for the pharmaceutical excipients market?
A3. The pharmaceutical excipients market is projected to grow at a CAGR of 9.17% over the forecast period.


Q4. How is the global pharmaceutical excipients market segmented?
A4. The pharmaceutical excipients market has been segmented by excipient type, formulation type, functionality, distribution channel, and geography.


Q5. What factors are anticipated to drive the pharmaceutical excipients market growth?
A5. With increasing chronic diseases, the growing generics market leads to an increase in the development of excipient is the major factor driving the pharmaceutical excipients market growth.

1. INTRODUCTION
1.1. Market Overview
1.2. Covid-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY  
2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY
3.1. Research Highlights

4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT TYPE
5.1. Introduction 
5.2. Polymers
5.3. Alcohols
5.4. Sugars
5.5. Minerals
5.6. Others

6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION TYPE
6.1. Introduction
6.2. Oral
6.3. Topical
6.4. Parenteral
6.5. Others

7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
7.1. Introduction
7.2. Coating Agents
7.3. Flavoring Agents & Sweeteners
7.4. Lubricants & Glidants
7.5. Colorants
7.6. Emulsifying Agents
7.7. Buffering Agents
7.8. Others

8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
8.1. Introduction 
8.2. Online
8.3. Offline

9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom 
9.4.4. Italy
9.4.5. Spain 
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Australia
9.6.3. Japan
9.6.4. South Korea
9.6.5. India
9.6.6. Thailand
9.6.7. Taiwan
9.6.8. Indonesia
9.6.9. Others

10. COMPETITIVE INTELLIGENCE
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrative
10.3. Mergers, Acquisition, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES
11.1. Ashland Global Holdings 
11.2. DuPont  
11.3. BASF SE
11.4. Roquette Feres  
11.5. Evonik Industries AG
11.6. Croda International 
11.7. Associated British Foods 
11.8.  Archer Daniels Midland Company  
11.9. Ingredion
11.10. Lubrizol Corporation 

Ashland Global Holdings

DuPont 

BASF SE

Roquette Feres 

Evonik Industries AG

Croda International

Associated British Foods

Archer Daniels Midland Company 

Lubrizol Corporation

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us